(19)
(11) EP 0 868 426 A1

(12)

(43) Date of publication:
07.10.1998 Bulletin 1998/41

(21) Application number: 97935012.0

(22) Date of filing: 18.07.1997
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
C12N 1/ 19( . )
C12N 15/ 82( . )
C07K 14/ 415( . )
C12N 5/ 10( . )
C12Q 1/ 68( . )
(86) International application number:
PCT/US1997/012626
(87) International publication number:
WO 1998/003536 (29.01.1998 Gazette 1998/04)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 23.07.1996 US 19960027228P

(71) Applicant: Novartis AG
4058 Basel (CH)

(72) Inventors:
  • LEBEL, Edouard, Guillaume
    Durham, NC 27713 (US)
  • RYALS, John, Andrew
    Cary, NC 27511 (US)
  • THORNE, Leigh
    Raleigh, NC 27606 (US)
  • UKNES, Scott, Joseph
    Apex, NC 27502 (US)
  • WARD, Eric, Russell
    Durham, NC 27705 (US)

(74) Representative: Bastian, Werner Maria, et al 
Novartis AG Geistiges Eigentum Konzern Patent- und Markenabteilung CH Postfach
4002 Basel
4002 Basel (CH)

   


(54) CHEMICALLY-INDUCIBLE ARABIDOPSIS PR-1 PROMOTER